Here's why Eli Lilly will sell a generic insulin

Mar 4, 2019
Lawmakers have been critical of big pharma's pricing structures.

Drugmakers of insulin accused of price fixing

Jan 31, 2017
Three of the biggest makers of diabetes treatments have been accused of price fixing. A lawsuit filed this week claims that Sanofi, Novo Nordisk and Eli Lilly have been conspiring to drive up prices of insulin at the expense of their patients. Because of the high prices, the suit says some patients have been using […]